Vertex Pharmaceuticals Incorporated technical analysis
Technical analysis of Vertex Pharmaceuticals Incorporated (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated is a biotechnology company that develops and commercializes medicines for serious diseases, with focus on cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain. The company distributes its products primarily through specialty pharmacies, distributors, wholesalers, retail pharmacies, hospitals, and clinics in the United States, Europe, and internationally.
Description generated automatically from public sources; it may be inaccurate or out of date.
Vertex Pharmaceuticals Incorporated: latest session data
Closing values for October 20, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
509.96 $
+0.92%
50 sessions
522.47 $
−1.50%
200 sessions
476.46 $
+8.01%
Session levels
s2
496.10
Support
s1
499.02
Support
pivot
502.43
Pivot
r1
505.35
Resistance
r2
508.76
Resistance
How to read it
In the October 20, 2026 session Vertex Pharmaceuticals Incorporated closed higher at 514.65 $, +2.53% versus the previous session.
The price sits mixed against its moving averages: +0.92% against the 21-session average, −1.50% against the 50 and +8.01% against the 200.
The 14-period RSI reads 52.4, in neutral territory.
MACD stands at -4.237 against a signal line at -4.861: the histogram is positive (+0.624).
ADX reads 20.3, indicating weak directionality.
Levels computed on the latest session place supports at 499.02 and 496.10 $ and resistances at 505.35 and 508.76 $, around a pivot of 502.43.
The average daily range (ATR) is 12.814 $, or 2.49% of price.
Turnover was 1.2M shares, 104% of the 20-session average.
Over the last twelve months the price ranged between 412.27 and 560.25 $, and today stands −8.14% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the VRTX analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Vertex Pharmaceuticals Incorporated
How is Vertex Pharmaceuticals Incorporated analysed technically?
Technical analysis of Vertex Pharmaceuticals Incorporated is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Vertex Pharmaceuticals Incorporated?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Vertex Pharmaceuticals Incorporated?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Vertex Pharmaceuticals Incorporated it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.